Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014

• Anna Kuehne ,

  * E-mail: Amanda.Tiffany@geneva.msf.org (AT); KuehneAn@rki.de (AK)

  Affiliations Postgraduate Training for Applied Epidemiology, Robert Koch Institute, Berlin, Germany, European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden, Epicentre, Paris, France

  ⨯
• Amanda Tiffany ,

  * E-mail: Amanda.Tiffany@geneva.msf.org (AT); KuehneAn@rki.de (AK)

  Affiliation Epicentre, Geneva, Switzerland

  ⨯
• Estrella Lasry,

  Affiliation Médecins Sans Frontières, Operational Centre Paris, Tropical Medicine, New York, New York, United States of America

  ⨯
• Michel Janssens,

  Affiliation Médecins Sans Frontières, Operational Centre Paris, Monrovia Project, Monrovia, Liberia

  ⨯
• Clement Besse,

  Affiliation Médecins Sans Frontières, Operational Centre Paris, Monrovia Project, Monrovia, Liberia

  ⨯
• Chibuzo Okonta,

  Affiliation Médecins Sans Frontières, Operational Centre Paris, Desk Urgence, Paris, France

  ⨯
• Kwabena Larbi,

  Affiliation Liberian National Malaria Control Programme, Ministry of Health, Monrovia, Liberia

  ⨯
• Alfred C. Pah,

  Affiliation Liberian National Malaria Control Programme, Ministry of Health, Monrovia, Liberia

  ⨯
• Kostas Danis,

  Affiliations European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden, Institut Veille Sanitaire, Paris, France

  ⨯
• Klaudia Porten

  Affiliation Epicentre, Paris, France

  ⨯